The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Pilot–Controlled Trial of the Extracorporeal Liver Assist Device in Acute Liver Failure
Open accessAbstract
The objective of this pilot controlled study was to evaluate the extracorporeal liver assist device (ELAD) in patients with acute liver failure who were judged to still have a significant chance of survival (approximately 50%) and in those who had already fulfilled criteria for transplantation. Twenty–four patients were divided into two groups, 17 with a potentially recoverable lesion (group I) and 7 listed for transplantation (group II), and then randomly allocated to ELAD haemoperfusion or control. The median period of ELAD haemoperfusion was 72 hours (range 3–168 h). Biocompatibility of the device was good, with no acceleration in platelet consumption, and haemodynamic stability was maintained. Two patients were withdrawn from the study because of worsening of preexisting disseminated intravascular coagulation in one case and a hypersensitivity reaction in the other. Deterioration with respect to encephalopathy grade was more frequent in the control patients, 7 of 12 (58%), than in the ELAD–treated patients, 3 of 12 (25%). In group I where survival for the ELAD cases was 7 of 9 (78%), there was a higher than expected survival in the controls, 6 of 8 (75%). For group II cases, survival was 1 of 3 (33%) for the ELAD– treated patients, and 1 of 4 (25%) for the controls. Both of the survivors underwent transplantation. Assessment of additive function for the device revealed an improvement in galactose elimination capacity after 6 hours of haemoperfusion. Based on the results of this pilot–controlled trial, better indices of prognosis will be required, in addition to those used to select for transplantation, if patients at an earlier stage of clinical deterioration are to be included in future studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Early indicators of prognosis in fulminant hepatic failure
O'Grady, J. G., Alexander, G. J. M., Hayllar, K. M., & Williams, R. (1989) · Gastroenterology · doi:10.1016/0016-5085(89)90081-4 · Cited by 2,085
Self-citationCraddock, P. R., Fehr, J., Dalmasso, A. P., Brighan, K. L., & Jacob, H. S. (1977) · Journal of Clinical Investigation · doi:10.1172/jci108710 · Cited by 991
Reversal of Fulminant Hepatic Failure Using An Extracorporeal Liver Assist Device
Sussman, N. L., Chong, M. G., Koussayer, T., He, D.-E., Shang, T. A., Whisennand, H. H., & Kelly, J. H. (1992) · Hepatology · doi:10.1002/hep.1840160112 · Cited by 345
Self-citationInfluence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor α
Herbelin, A., Nguyen, A. T., Zingraff, J., Ureña, P., & Descamps-Latscha, B. (1990) · Kidney International · doi:10.1038/ki.1990.16 · Cited by 336
The Hepatix Extracorporeal Liver Assist Device: Initial Clinical Experience
Sussman, N. L., Gislason, G. T., Conlin, C. A., & Kelly, J. H. (1994) · Artificial Organs · doi:10.1111/j.1525-1594.1994.tb02221.x · Cited by 277
Self-citationCoagulopathy of Fulminant Hepatic Failure
O’Grady, J., Langley, P. G., Isola, L. M., Aledort, L. M., & Williams, R. L. (1986) · Seminars in Liver Disease · doi:10.1055/s-2008-1040599 · Cited by 76
Self-citationAn improved model of acetaminophen-induced fulminant hepatic failure in dogs
Kelly, J. H., Koussayer, T., He, D.-E., Chong, M. G., Shang, T. A., Whisennand, H. H., & Sussman, N. (1992) · Hepatology · doi:10.1002/hep.1840150225 · Cited by 76
Self-citationNyberg, S. L., Shatford, R. A. D., Hu, W., Payne, W. D., & Cerra, F. B. (1992) · Critical Care Medicine · doi:10.1097/00003246-199208000-00016 · Cited by 71
Mammalian hepatocytes as a foundation for treatment in human liver failure
Jauregui, H., & Gann, K. L. (1991) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240450409 · Cited by 55
Assessment of an Extracorporeal Liver Assist Device in Anhepatic Dogs
Kelly, J. H., Koussayer, T., He, D.-E., Chong, M. G., Shang, T. A., Whisennand, H. H., & Sussman, N. (1992) · Artificial Organs · doi:10.1111/j.1525-1594.1992.tb00543.x · Cited by 54
Self-citationEffect of ELAD Liver Support on Plasma HGF and TGF–β 1 in Acute Liver Failure
Miwa, Y., Ellis, A. J., Hughes, R. D., Langley, P. G., Wendon, J. A., & Williams, R. L. (1996) · The International Journal of Artificial Organs · doi:10.1177/039139889601900406 · Cited by 26
Self-citationNew Directions in Acute Liver Failure
Williams, R. L. (1994) · Journal of the Royal College of Physicians of London · doi:10.1016/s0035-8819(25)00701-9 · Cited by 8
Self-citation
Cited by
AASLD position paper: The management of acute liver failure†
Polson, J., & Lee, W. M. (2005) · Hepatology · doi:10.1002/hep.20703 · Cited by 974
Demetriou, A. A., Brown, R. S., Busuttil, R. W., Fair, J., McGuire, B. M., Rosenthal, P., Am Esch, J. S., Lerut, J., Nyberg, S. L., Salizzoni, M., et al. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000124298.74199.e5 · Cited by 677
Lee, W. M., Stravitz, T. R., & Larson, A. M. (2012) · Hepatology · doi:10.1002/hep.25551 · Cited by 550
Kjaergard, L. L., Liu, J., Als-Nielsen, B., & Gluud, C. (2003) · JAMA · doi:10.1001/jama.289.2.217 · Cited by 379
Tilles, A. W., Baskaran, H., Roy, P., Yarmush, M. L., & Toner, M. (2001) · Biotechnology and Bioengineering · doi:10.1002/bit.1071 · Cited by 330
Metadata
- Authors
- Ellis, A. J., Hughes, R. D., Wendon, J. A., Dunne, J., Langley, P. G., Kelly, J. H., Gislason, G. T., Sussman, N. L., & Williams, R.
- Venue
- Hepatology
- Published
- 1996-12
- Volume
- 24
- Issue
- 6
- Pages
- 1446-1451
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2119636014
- Cited by
- 513
- References
- 12
- FWCI
- 9.53
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.